Teramoto Kanako, Tay Wan Ting, Tromp Jasper, Katherine Teng Tiew-Hwa, Chandramouli Chanchal, Ouwerkerk Wouter, Lawson Claire A, Huang Weiting, Hung Chung-Lieh, Chopra Vijay, Anand Inder, Mark Richards Arthur, Lam Carolyn S P
National Heart Centre Singapore (K.T., W.T.T., J.T., T.-H.K.T., C.C., W.O., W.H., C.S.P.L.).
National Cerebral and Cardiovascular Center, Osaka, Japan (K.T.).
Circ Cardiovasc Qual Outcomes. 2023 Jan;16(1):e009134. doi: 10.1161/CIRCOUTCOMES.122.009134. Epub 2022 Dec 9.
We aimed to assess if discordance between patient-reported Kansas City Cardiomyopathy Questionnaire (KCCQ)-overall summary (os) score and physician-assessed New York Heart Association (NYHA) class is common among patients with heart failure (HF) with reduced or preserved ejection fraction, and determine its association with outcomes.
A total of 4818 patients with HF were classified according to KCCQ-os score (range 0-100, dichotomized by median value 71.9 into high [good] versus low [bad]) and NYHA class (I/II [good] or III/IV [bad]) as concordant good (low NYHA class, high KCCQ-os score), concordant bad (high NYHA class, low KCCQ-os score), discordant worse NYHA class (high NYHA class, high KCCQ-os score), and discordant worse KCCQ-os score (low NYHA class, low-KCCQ-os score). The composite of HF hospitalization or death at 1 year was compared across groups.
There were 2070 (43.0%) concordant good, 1099 (22.8%) concordant bad, 331 (6.9%) discordant worse NYHA class, and 1318 (27.4%) discordant worse KCCQ-os score patients. Compared with concordant good, adverse outcomes were the highest in concordant bad (HR, 2.7 [95% CI, 2.2-3.5]) followed by discordant worse KCCQ-os score (HR, 1.8 [95% CI, 1.4-2.2]) and discordant worse NYHA class (HR, 1.5 [95% CI, 1.0-2.3]); with no modification by HF phenotype (preserved versus reduced ejection fraction, =0.52). At 6 months, 1403 (48%) experienced clinically significant improvement in KCCQ-os score (≥5 points increase over 6 months). Patients with improved KCCQ-os at 6 months (HR, 0.65 [95% CI, 0.47-0.92]) had better outcomes and the association was not modified by HF phenotype (=0.40).
One-third of patients with HF had discordance between patient-reported and clinician-assessed health status, largely attributable to worse patient-reported outcomes. Such discordance, particularly in those with discordantly worse KCCQ, should alert physicians to an increased risk of HF hospitalization and death, and prompt further assessment for potential drivers of worse patient-reported outcomes relative to physicians' assessment.
我们旨在评估在射血分数降低或保留的心力衰竭(HF)患者中,患者报告的堪萨斯城心肌病问卷(KCCQ)总体总结(os)评分与医生评估的纽约心脏协会(NYHA)心功能分级之间的不一致是否常见,并确定其与预后的关联。
总共4818例HF患者根据KCCQ-os评分(范围0-100,以中位数71.9分为界分为高[良好]与低[不良])和NYHA分级(I/II[良好]或III/IV[不良])分为一致良好(NYHA分级低,KCCQ-os评分高)、一致不良(NYHA分级高,KCCQ-os评分低)、NYHA分级不一致更差(NYHA分级高,KCCQ-os评分高)和KCCQ-os评分不一致更差(NYHA分级低,KCCQ-os评分低)。比较各组1年内心力衰竭住院或死亡的复合终点。
有2070例(43.0%)一致良好,1099例(22.8%)一致不良,331例(6.9%)NYHA分级不一致更差,1318例(27.4%)KCCQ-os评分不一致更差的患者。与一致良好组相比,不良结局在一致不良组中最高(HR,2.7[95%CI,2.2-3.5]),其次是KCCQ-os评分不一致更差组(HR,1.8[95%CI,1.4-2.2])和NYHA分级不一致更差组(HR,1.5[95%CI,1.0-2.3]);心力衰竭表型(保留与降低的射血分数,P=0.52)对此无影响。在6个月时,1403例(48%)患者的KCCQ-os评分有临床显著改善(6个月内增加≥5分)。6个月时KCCQ-os评分改善的患者(HR,0.65[95%CI,0.47-0.92])预后更好,且该关联不受心力衰竭表型影响(P=0.40)。
三分之一的HF患者在患者报告的和医生评估的健康状况之间存在不一致,这主要归因于患者报告的结局更差。这种不一致,特别是在KCCQ不一致更差的患者中,应提醒医生注意心力衰竭住院和死亡风险增加,并促使进一步评估相对于医生评估而言患者报告结局更差的潜在驱动因素。